Bayer’s Mark Sargent re-elected as ASMI President
20 November 2014 - The Australian Self
Medication Industry (ASMI) today announced the re-election of Mark
Sargent, General Manager Consumer Care Australia & New
Zealand, Bayer Australia Limited, as its President.
Speaking on his re-election, Mark Sargent said: "I am delighted to continue for another term as President to advance a strong, sustainable non-prescription medicines industry and to drive ASMI's long-term strategic goal of having self care integrated into healthcare policy.
"I look forward to continuing to work with ASMI's Committee of
Management, the broader membership and key stakeholders to achieve
these goals and to further drive growth and innovation in the OTC
and complementary medicines sectors."
Mark Sargent has over 20 years' experience in senior marketing, sales and management roles, including 15 years in the OTC and complementary medicines sectors in Australia and globally. His most recent achievement has been the successful integration of MSD Consumer Care, which was acquired by Bayer in October.
ASMI Executive Director Dr Deon Schoombie commented that Mark
Sargent had been a great source of strategic advice and counsel for
ASMI over many years and members will benefit greatly from his
third consecutive year of leadership.
"We are delighted that Mark will continue for another term in his role as President to deliver the programs that will help elevate self care on the healthcare policy agenda," he added.
Dr Schoombie also congratulated the other ASMI office-bearers for 2015:
- Violeta Delgado, newly elected Vice President (Treasurer), Head of ANZ at Novartis Consumer Health.
- Re-elected ASMI Vice President (Secretary) Paul Rose, General Manager ANZ at Pfizer Consumer Healthcare.
For more information or to arrange a media interview, please
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: firstname.lastname@example.org
About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines (CM). ASMI members make up 85 per cent of the $4bn Non-Prescription Medicines market. Membership totals 50 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to advance consumer health through responsible self-care. This means driving a viable and responsible industry and empowering the consumer with evidence-based products and information with the aim of improving health and wellbeing. To find out more about ASMI or how to become an ASMI member, please visit (www.asmi.com.au).